HSPC secreted factors, such as CXCL10 have not been evaluated in the setting of drug resistance in AML, but have been suggested to promote chemoresistance [50] and blast migration to the BM of an acute lymphoblastic leukemia model [51]. The gene discussed is CXCL10; the disease is acute myeloid leukemia.